Dementia of Alzheimer Type: Clinical Trials

5 trials for Dementia of Alzheimer Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Recruiting 1
Phase 11Recruiting 1
Phase 31Completed 1

Follow Dementia of Alzheimer Type: new trials by email Literature Review of Dementia of Alzheimer Type trials Research Report on Dementia of Alzheimer Type

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DMB-I in the Treatment of Alzheimer Type Dementia
DMB-I (Dimebon), Placebo - Alzheimer Disease, Dementia of Alzheimer Type
Phase 2CompletedBigespas LTD1332023-12-272025-03-28
Assess Fibrin in Brains With AD/ADRD
PET/MR Imaging, 64Cu-FBP8 - Alzheimer Disease, Dementia of Alzheimer Type
Phase 1 / Phase 2RecruitingMassachusetts General Hospital302022-03-292025-10-30
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
ATH-1017, Placebo - Alzheimer Disease, Dementia of Alzheimer Type
Phase 2CompletedLeonaBio772020-11-232023-06-12
ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
ATH-1017, Placebo - Alzheimer Disease, Dementia of Alzheimer Type
Phase 2 / Phase 3CompletedLeonaBio5542020-09-282025-04-04
Treating Hyperexcitability in AD With Levetiracetam
Levetiracetam, Placebo oral capsule - Alzheimer Dementia, Alzheimer Disease
Phase 2CompletedBeth Israel Deaconess Medical Center582019-08-222026-04-07

Narrower conditions

Alzheimer Disease (5)  ·  Dementia (3)  ·  Cognitive Dysfunction (1)  ·  Memory Disorders (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Mental Disorders (5)  ·  Nervous System Diseases (5)  ·  Neurocognitive Disorders (5)  ·  Neurodegenerative Diseases (5)  ·  Tauopathies (5)  ·  Dementia (2)  ·  Cognition Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Levetiracetam (1)  ·  Magnetic Resonance Imaging (1)  ·  Positron-Emission Tomography (1)  ·  latrepirdine (1)

Sponsors

LeonaBio (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Bigespas LTD (1)  ·  Massachusetts General Hospital (1)

Countries

United States (4)  ·  Australia (1)  ·  Russia (1)

Top investigators

Ciprian Catana, MD, PhD (1)  ·  Javier San Martin, MD (1)

Results publications

PMID 38599894, PMID 41313764, PMID 41574278, PMID 42141012

NIH funding

R01AG068268 (1), R01HL109448 (1)